You are here »
Home »
Company » Glaxosmithkline Pharmaceuticals Ltd
Glaxosmithkline Pharmaceuticals Ltd.
BSE: 500660 |
Sector: Health care |
NSE: GLAXO |
ISIN Code: INE159A01016 |
BSE
12:33 | 16 May
|
1506.65
|
15.00 (1.01%)
|
OPEN
1499.00
|
HIGH
1509.75
|
LOW
1482.00
|
NSE
12:19 | 16 May
|
1506.95
|
13.65 (0.91%)
|
OPEN
1495.00
|
HIGH
1510.75
|
LOW
1490.70
|
OPEN |
1499.00 |
PREVIOUS CLOSE |
1491.65 |
VOLUME |
541 |
52-Week high |
1917.00 |
52-Week low |
1433.05 |
P/E |
48.70 |
Mkt Cap.(Rs cr) |
25,524 |
Buy Price |
1506.65 |
Buy Qty |
1.00 |
Sell Price |
1508.95 |
Sell Qty |
7.00 |
OPEN |
1495.00 |
PREVIOUS CLOSE |
1493.30 |
VOLUME |
4331 |
52-Week high |
1918.75 |
52-Week low |
1449.00 |
P/E |
48.70 |
Mkt Cap.(Rs cr) |
25,524 |
Buy Price |
1506.00 |
Buy Qty |
2.00 |
Sell Price |
1507.00 |
Sell Qty |
10.00 |
OPEN |
1499.00 |
CLOSE |
1491.65 |
VOLUME |
541 |
52-Week high |
1917.00 |
52-Week low |
1433.05 |
P/E |
48.70 |
Mkt Cap.(Rs cr) |
25,524 |
Buy Price |
1506.65 |
Buy Qty |
1.00 |
Sell Price |
1508.95 |
Sell Qty |
7.00 |
OPEN |
1495.00 |
PREVIOUS CLOSE |
1493.30 |
VOLUME |
4331 |
52-Week high |
1918.75 |
52-Week low |
1449.00 |
P/E |
48.70 |
Mkt Cap.(Rs cr) |
25524.16 |
Buy Price |
1506.00 |
Buy Qty |
2.00 |
Sell Price |
1507.00 |
Sell Qty |
10.00 |
About Glaxosmithkline Pharmaceuticals Ltd.
Glaxosmithkline Pharmaceuticals Ltd
GlaxoSmithKline Pharmaceuticals Ltd is one of the leading pharmaceutical companies in the India. It is a subsidiary of GlaxoSmithKline plc UK one of the world's leading research-based pharmaceutical and healthcare companies. The company's product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives dermatology g...> More
Glaxosmithkline Pharmaceuticals Ltd - Key Fundamentals
Glaxosmithkline Pharmaceuticals Ltd - Financial Results
Particulars ( cr) |
Dec 2021 |
Dec 2020 |
% Chg |
Net Sales |
815.92 |
791.87 |
3.04 |
Other Income |
22.39 |
41.81 |
-46.45 |
Total Income |
838.31 |
833.68 |
0.56 |
Total Expenses |
636.03 |
611.21 |
4.06 |
Operating Profit |
202.28 |
222.47 |
-9.08 |
Net Profit |
150.35 |
156.51 |
-3.94 |
Equity Capital |
169.41 |
169.41 |
- |
> More on Glaxosmithkline Pharmaceuticals Ltd Financials Results
Glaxosmithkline Pharmaceuticals Ltd - Peer Group
Glaxosmithkline Pharmaceuticals Ltd - SHAREHOLDING PATTERN
Glaxosmithkline Pharmaceuticals Ltd - Research Reports
Glaxosmithkline Pharmaceuticals Ltd - RETURNS
Period |
BSE |
NSE |
Sensex |
NIFTY |
1 Week |
-1.47% |
-1.38% |
-2.77% |
-2.81% |
1 Month |
-8.50% |
-8.58% |
-9.21% |
-9.34% |
3 Month |
-4.22% |
-4.15% |
-8.68% |
-8.54% |
6 Month |
-7.84% |
-7.70% |
-12.20% |
-11.98% |
1 Year |
0.19% |
0.19% |
8.68% |
7.94% |
3 Year |
17.74% |
17.75% |
41.64% |
40.74% |
Glaxosmithkline Pharmaceuticals Ltd - STOCK STRENGTH
Today's Low/High |
1482.00 |
|
1509.75 |
Week Low/High |
1433.05 |
|
1552.00 |
Month Low/High |
1433.05 |
|
1671.00 |
YEAR Low/High |
1433.05 |
|
1917.00 |
All TIME Low/High |
12.88 |
|
1925.00 |
Quick Links for Glaxosmithkline Pharmaceuticals: